Literature DB >> 19710633

Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice.

Marco Bortolato1, Sean C Godar, Shieva Davarian, Kevin Chen, Jean C Shih.   

Abstract

Monoamine oxidase (MAO) B catalyzes the degradation of beta-phenylethylamine (PEA), a trace amine neurotransmitter implicated in mood regulation. Although several studies have shown an association between low MAO B activity in platelets and behavioral disinhibition in humans, the nature of this relation remains undefined. To investigate the impact of MAO B deficiency on the emotional responses elicited by environmental cues, we tested MAO B knockout (KO) mice in a set of behavioral assays capturing different aspects of anxiety-related manifestations, such as the elevated plus maze, defensive withdrawal, marble burying, and hole board. Furthermore, MAO B KO mice were evaluated for their exploratory patterns in response to unfamiliar objects and risk-taking behaviors. In comparison with their wild-type (WT) littermates, MAO B KO mice exhibited significantly lower anxiety-like responses and shorter latency to engage in risk-taking behaviors and exploration of unfamiliar objects. To determine the neurobiological bases of the behavioral differences between WT and MAO B KO mice, we measured the brain-regional levels of PEA in both genotypes. Although PEA levels were significantly higher in all brain regions of MAO B KO in comparison with WT mice, the most remarkable increments were observed in the striatum and prefrontal cortex, two key regions for the regulation of behavioral disinhibition. However, no significant differences in transcript levels of PEA's selective receptor, trace amine-associated receptor 1 (TAAR1), were detected in either region. Taken together, these results suggest that MAO B deficiency may lead to behavioral disinhibition and decreased anxiety-like responses partially through regional increases of PEA levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710633      PMCID: PMC2783894          DOI: 10.1038/npp.2009.118

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  115 in total

1.  Monoamine oxidases of the human brain and liver.

Authors:  R N Kalaria; M J Mitchell; S I Harik
Journal:  Brain       Date:  1988-12       Impact factor: 13.501

2.  Phenylethylamine relieves depression after selective MAO-B inhibition.

Authors:  H Sabelli; R Fahrer; R D Medina; E Ortiz Fragola
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1994       Impact factor: 2.198

3.  Investigating potential anxiolytic, antidepressant and memory enhancing activity of deprenyl.

Authors:  E Nowakowska; K Kus; A Chodera; J Rybakowski
Journal:  J Physiol Pharmacol       Date:  2001-12       Impact factor: 3.011

4.  Behavioral disinhibition requires dopamine receptor activation.

Authors:  Marcel M van Gaalen; Reinhild J Brueggeman; Patricia F C Bronius; Anton N M Schoffelmeer; Louk J M J Vanderschuren
Journal:  Psychopharmacology (Berl)       Date:  2006-04-25       Impact factor: 4.530

Review 5.  Selegiline in treatment of behavioral and cognitive symptoms of Alzheimer disease.

Authors:  S R Tolbert; M A Fuller
Journal:  Ann Pharmacother       Date:  1996-10       Impact factor: 3.154

6.  Methamphetamine induces long-term alterations in reactivity to environmental stimuli: correlation with dopaminergic and serotonergic toxicity.

Authors:  Marco Bortolato; Roberto Frau; A Paola Piras; William Luesu; Valentina Bini; Giacomo Diaz; Gianluigi Gessa; M Grazia Ennas; M Paola Castelli
Journal:  Neurotox Res       Date:  2009-02-25       Impact factor: 3.911

7.  Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness.

Authors:  J Mendlewicz; M B Youdim
Journal:  J Affect Disord       Date:  1980-06       Impact factor: 4.839

8.  Novel monoamine oxidase A knock out mice with human-like spontaneous mutation.

Authors:  Anna L Scott; Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Neuroreport       Date:  2008-05-07       Impact factor: 1.837

9.  Structure of rat behavior in hole-board: I) multivariate analysis of response to anxiety.

Authors:  Maurizio Casarrubea; Filippina Sorbera; Giuseppe Crescimanno
Journal:  Physiol Behav       Date:  2008-10-09

10.  Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes.

Authors:  J W Lenders; G Eisenhofer; N G Abeling; W Berger; D L Murphy; C H Konings; L M Wagemakers; I J Kopin; F Karoum; A H van Gennip; H G Brunner
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

View more
  36 in total

1.  The learned safety paradigm as a mouse model for neuropsychiatric research.

Authors:  Daniela D Pollak; Francisco J Monje; Gert Lubec
Journal:  Nat Protoc       Date:  2010-04-29       Impact factor: 13.491

2.  2-Pentadecyl-2-Oxazoline Reduces Neuroinflammatory Environment in the MPTP Model of Parkinson Disease.

Authors:  Marika Cordaro; Rosalba Siracusa; Rosalia Crupi; Daniela Impellizzeri; Alessio Filippo Peritore; Ramona D'Amico; Enrico Gugliandolo; Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  Mol Neurobiol       Date:  2018-04-14       Impact factor: 5.590

Review 3.  Transcriptional regulation and multiple functions of MAO genes.

Authors:  Jean C Shih; Jason Boyang Wu; Kevin Chen
Journal:  J Neural Transm (Vienna)       Date:  2011-02-27       Impact factor: 3.575

4.  Head rotational acceleration characteristics influence behavioral and diffusion tensor imaging outcomes following concussion.

Authors:  Brian D Stemper; Alok S Shah; Frank A Pintar; Michael McCrea; Shekar N Kurpad; Aleksandra Glavaski-Joksimovic; Christopher Olsen; Matthew D Budde
Journal:  Ann Biomed Eng       Date:  2014-10-25       Impact factor: 3.934

5.  Granulocyte-macrophage colony-stimulating factor is neuroprotective in experimental traumatic brain injury.

Authors:  Sandy R Shultz; Xin L Tan; David K Wright; Shijie J Liu; Bridgette D Semple; Leigh Johnston; Nigel C Jones; Andrew D Cook; John A Hamilton; Terence J O'Brien
Journal:  J Neurotrauma       Date:  2014-03-07       Impact factor: 5.269

6.  Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma.

Authors:  Pei Chuan Li; Imran N Siddiqi; Anja Mottok; Eric Y Loo; Chieh Hsi Wu; Wendy Cozen; Christian Steidl; Jean Chen Shih
Journal:  J Pathol       Date:  2017-09-05       Impact factor: 7.996

7.  Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors.

Authors:  Laura J Mosher; Sean C Godar; Marc Morissette; Kenneth M McFarlin; Simona Scheggi; Carla Gambarana; Stephen C Fowler; Thérèse Di Paolo; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2018-02-16       Impact factor: 4.905

8.  Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice.

Authors:  Marco Bortolato; Sean C Godar; Simone Tambaro; Felix G Li; Paola Devoto; Marcelo P Coba; Kevin Chen; Jean C Shih
Journal:  Neuropharmacology       Date:  2013-07-16       Impact factor: 5.250

Review 9.  The role of monoamine oxidase A in aggression: Current translational developments and future challenges.

Authors:  Sean C Godar; Paula J Fite; Kenneth M McFarlin; Marco Bortolato
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-01-09       Impact factor: 5.067

10.  Sociocommunicative and sensorimotor impairments in male P2X4-deficient mice.

Authors:  Letisha R Wyatt; Sean C Godar; Sheraz Khoja; Michael W Jakowec; Ronald L Alkana; Marco Bortolato; Daryl L Davies
Journal:  Neuropsychopharmacology       Date:  2013-04-19       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.